On the stock market since 1997, it operates in the world of health and science. Now — the numbers.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
An average decline of 95% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Nothing in the current numbers stands out as a strong positive. That, by itself, is worth knowing.
A loss of $2.7M against $15K in annual sales. And on top of that, sales fell from the year before.
The stock sits at $0.39. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
This stock swings about 2.6 times as much as the market average. Big rallies — and big drops — can both happen fast.
On our five-subject report card, CBTE sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: CBTE is a small company that closed last year at a loss. The road back to profit runs through spending discipline.